Trexquant Investment LP purchased a new position in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,509 shares of the company's stock, valued at approximately $409,000.
Other large investors have also bought and sold shares of the company. New York State Common Retirement Fund bought a new stake in shares of Bowhead Specialty in the 4th quarter worth approximately $64,000. US Bancorp DE bought a new stake in shares of Bowhead Specialty during the 4th quarter valued at $76,000. KLP Kapitalforvaltning AS purchased a new stake in Bowhead Specialty during the 4th quarter worth about $107,000. Pictet Asset Management Holding SA purchased a new position in Bowhead Specialty during the 4th quarter valued at about $145,000. Finally, Corebridge Financial Inc. grew its position in Bowhead Specialty by 49.9% in the fourth quarter. Corebridge Financial Inc. now owns 5,787 shares of the company's stock worth $206,000 after acquiring an additional 1,926 shares in the last quarter.
Insider Transactions at Bowhead Specialty
In other Bowhead Specialty news, Director Ava Schnidman acquired 1,493 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were acquired at an average cost of $33.41 per share, with a total value of $49,881.13. Following the transaction, the director now owns 1,893 shares of the company's stock, valued at $63,245.13. The trade was a 373.25 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Analysts Set New Price Targets
BOW has been the topic of a number of recent research reports. JPMorgan Chase & Co. raised their price objective on Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research note on Tuesday, April 8th. Piper Sandler assumed coverage on Bowhead Specialty in a research report on Wednesday. They issued an "overweight" rating and a $44.00 price objective for the company. JMP Securities lifted their target price on shares of Bowhead Specialty from $38.00 to $40.00 and gave the stock a "market outperform" rating in a research note on Friday, April 11th. Finally, Keefe, Bruyette & Woods decreased their price objective on shares of Bowhead Specialty from $44.00 to $43.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $37.17.
Check Out Our Latest Analysis on BOW
Bowhead Specialty Price Performance
Shares of BOW stock traded up $0.31 during trading hours on Friday, hitting $40.14. 210,798 shares of the company's stock traded hands, compared to its average volume of 212,890. The stock's fifty day simple moving average is $36.29 and its two-hundred day simple moving average is $34.02. Bowhead Specialty Holdings Inc. has a 12-month low of $22.14 and a 12-month high of $42.29.
Bowhead Specialty (NYSE:BOW - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.07. The company had revenue of $184.77 million during the quarter, compared to analysts' expectations of $102.12 million. Equities research analysts forecast that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current fiscal year.
Bowhead Specialty Company Profile
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Further Reading
Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
